Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Current Assets (2020 - 2025)

BioAtla (BCAB) has disclosed Current Assets for 6 consecutive years, with $8.0 million as the latest value for Q4 2025.

  • For Q4 2025, Current Assets fell 84.36% year-over-year to $8.0 million; the TTM value through Dec 2025 reached $8.0 million, down 84.36%, while the annual FY2025 figure was $8.0 million, 84.36% down from the prior year.
  • Current Assets hit $8.0 million in Q4 2025 for BioAtla, down from $9.7 million in the prior quarter.
  • Across five years, Current Assets topped out at $273.5 million in Q3 2021 and bottomed at $8.0 million in Q4 2025.
  • Average Current Assets over 5 years is $138.6 million, with a median of $161.4 million recorded in 2023.
  • Year-over-year, Current Assets grew 2.75% in 2021 and then tumbled 84.36% in 2025.
  • BioAtla's Current Assets stood at $247.3 million in 2021, then decreased by 10.86% to $220.4 million in 2022, then plummeted by 47.19% to $116.4 million in 2023, then crashed by 55.99% to $51.2 million in 2024, then plummeted by 84.36% to $8.0 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $8.0 million, $9.7 million, and $20.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.